| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | G1 Therapeutics, Inc. | GTHX | Grant | Common Stock | 10k | $0.00 | $0 | | 06/15/2023 |
| 06/15/2023 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Options (Right to Buy) | 30k | $2.83 | $84.9k | | 06/15/2023 |
| 09/12/2022 | Day One Biopharmaceuticals, Inc. | | Grant | Stock Option (Right to buy Common Stock) | 33.9k | $25.84 | $876k | | 09/12/2022 |
| 08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 23.4k | $59.11 | $1.4M | | 08/17/2022 |
| 08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 8.5k | $65.64 | $557.9k | | 08/17/2022 |
| 06/23/2022 | NextCure, Inc. | NXTC | Grant | Stock Option (Right to Buy) | 14.2k | $4.77 | $68k | | 06/23/2022 |
| 06/23/2022 | G1 Therapeutics, Inc. | GTHX | Grant | Common Stock | 10k | $0.00 | $0 | | 06/23/2022 |
| 06/23/2022 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Options (Right to Buy) | 30k | $5.30 | $159k | | 06/23/2022 |
| 06/24/2021 | NextCure, Inc. | NXTC | Grant | Stock Option (Right to Buy) | 14.2k | $8.21 | $117k | | 06/24/2021 |
| 06/17/2021 | G1 Therapeutics, Inc. | GTHX | Grant | Common Stock | 4.4k | $0.00 | $0 | | 06/17/2021 |
| 06/17/2021 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Options (Right to Buy) | 19.6k | $21.97 | $431.1k | | 06/17/2021 |
| 06/02/2021 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 8.5k | $65.64 | $557.9k | | 06/02/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 15k | $29.80 | $447k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 10k | $17.27 | $172.7k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 15k | $6.09 | $91.4k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 20k | $4.14 | $82.8k | | 04/16/2021 |
| 06/15/2020 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 25k | $59.11 | $1.5M | | 06/15/2020 |
| 06/15/2020 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 23.4k | $59.11 | $1.4M | | 06/15/2020 |
| 06/11/2020 | NextCure, Inc. | NXTC | Grant | Stock Option (Right to Buy) | 16.1k | $24.13 | $388.1k | | 06/11/2020 |
| 06/11/2020 | NextCure, Inc. | NXTC | Grant | Stock Option (Right to Buy) | 28.5k | $24.13 | $687.7k | | 06/11/2020 |
| 06/11/2020 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $17.59 | $351.8k | | 06/11/2020 |
| 05/14/2020 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 20k | $4.14 | $82.8k | | 05/14/2020 |
| 01/22/2020 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 25k | $59.11 | $1.5M | | 01/22/2020 |
| 06/12/2019 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $18.47 | $369.4k | | 06/12/2019 |
| 06/12/2019 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 100k | $18.47 | $1.8M | | 06/12/2019 |
| 06/10/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 15k | $6.09 | $91.4k | | 06/10/2019 |
| 01/22/2019 | TESARO, Inc. | TSRO | Other | Common Stock | 1.7k | $75.00 | $125.3k | | 01/22/2019 |
| 01/22/2019 | TESARO, Inc. | TSRO | Disposition | Director Restricted Stock Units | 4.1k | $0.00 | $0 | | 01/22/2019 |
| 01/22/2019 | TESARO, Inc. | TSRO | Disposition | Director Nonqualified Stock Option (right to buy) | 25k | $60.77 | $1.5M | | 01/22/2019 |
| 01/22/2019 | TESARO, Inc. | TSRO | Disposition | Director Nonqualified Stock Option (right to buy) | 12k | $47.27 | $567.2k | | 01/22/2019 |
| 01/22/2019 | TESARO, Inc. | TSRO | Disposition | Director Nonqualified Stock Option (right to buy) | 12k | $149.22 | $1.8M | | 01/22/2019 |
| 01/22/2019 | TESARO, Inc. | TSRO | Disposition | Director Nonqualified Stock Option (right to buy) | 7.2k | $46.89 | $338k | | 01/22/2019 |
| 09/12/2018 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $65.75 | $1.3M | | 09/12/2018 |
| 06/01/2018 | TESARO, Inc. | TSRO | Grant | Director Nonqualified Stock Option (right to buy) | 7.2k | $46.89 | $338k | | 06/01/2018 |
| 06/01/2018 | TESARO, Inc. | TSRO | Grant | Director Restricted Stock Units | 4.1k | $0.00 | $0 | | 06/01/2018 |
|